rs201238819
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS1
The NM_001009944.3(PKD1):c.8087T>G(p.Leu2696Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L2696F) has been classified as Uncertain significance.
Frequency
Consequence
NM_001009944.3 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant polycystic kidney diseaseInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- polycystic kidney disease 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- autosomal recessive polycystic kidney diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Caroli diseaseInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PKD1 | NM_001009944.3 | c.8087T>G | p.Leu2696Arg | missense_variant | Exon 22 of 46 | ENST00000262304.9 | NP_001009944.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00150 AC: 218AN: 145412Hom.: 0 Cov.: 20 show subpopulations
GnomAD2 exomes AF: 0.00108 AC: 184AN: 170576 AF XY: 0.00112 show subpopulations
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000412 AC: 596AN: 1447962Hom.: 1 Cov.: 30 AF XY: 0.000417 AC XY: 300AN XY: 720112 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome AF: 0.00150 AC: 219AN: 145524Hom.: 0 Cov.: 20 AF XY: 0.00151 AC XY: 107AN XY: 70886 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Polycystic kidney disease Benign:1
The PKD1 p.Leu2696Arg variant was identified in 14 of 286 proband chromosomes (frequency: 0.049) from individuals or families with ADPKD, and was not identified in 100 control chromosomes from healthy individuals (Phakdeekitcharoen 2001, Bataille 2011, Yu 2011). The p.Leu2696Arg variant was identified in the dbSNP (ID: rs201238819) with no known clinical significance. The variant was not identified in NHLBI Exome Sequencing Project (Exome Variant Server). The variant was identified in Exome Aggregation Consortium (March 14, 2016), in 42 of 19230 chromosomes (frequency: 0.002) or 10 of 8070 South Asians, 24 of 7400 European (Non-Finnish), 2 of 628 Latino, 5 of 1616 African and 1 of 178 Other populations and not found in East Asian and European (Finnish), increasing the likelihood this could be a low frequency benign variant. The variant was identified in the PKD Mutation Database and was classified as likely neutral. The p.Leu2696 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein. However, this information is not predictive enough to rule out pathogenicity. In a study of 41 Thai probands with ADPKD and pathogenic variants in the replicated portion of the PKD1 gene, the p.Leu2696Arg variant was identified to occur in non-conservative region within the REJ domain, but its effect on the three-dimensional structure is unknown. Glutamic acid and arginine are observed in the corresponding positions of Fugu and murine polycystin-1, respectively, suggesting a noncritical role for a nonpolar residue at this location (Phakdeekitcharoen 2001). In ADPKD family studies, the variant was identified in a fetus with cystic kidneys resembling ADPKD on ultrasound however it co-occurred with a de novo PKD1 “likely pathogenic” variant (c.9222C>G, p.Asn3074Lys. The fetus was also identified to carry a HNF1β “highly likely pathogenic” variant (c.883C>T, p.Arg295Cys) which was also identified in the father and paternal grandmother who had cystic kidneys consistent with the HNF1β phenotype. The PKD1 p.Leu2696Arg variant was inherited from the mother with a normal renal phenotype. (Bergmann_2011_22034641). In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as Benign. -
not provided Benign:1
PKD1: BP4 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at